Barclays Ventures and Eagle Labs are proud to partner with organisations who share our belief in open collaboration. We want to hear from organisations who embrace new emerging technologies to solve problems affecting key sectors across the UK.
These are clearly challenging times, not just for the UK but globally. This week three of our partners - The University of Edinburgh, UCL and CodeBase - opened a collaborative effort on how technology, innovation and their connected networks can quickly help support the NHS response to the current COVID-19 crisis. The partnership is particularly focused on ways that existing tech solutions can address the isolation of the vulnerable, reduce non-critical demand into the NHS and aid diagnostics and treatment.
Our partners have kindly asked if Barclays Ventures and Eagle Labs can support their efforts, of which we’re only glad to.
And we’re hoping you can help too.
Do you have a tech solution or innovative idea on how to address one or more of the following key challenges? If so, the partnership could help fast track deployment.
Slowing the Spread of COVID-19
Tools to educate on the ways to reduce the spread of the disease
Communication platforms to drive behavioural change
Enabling Home-based Care
To support remote or self-managed triage solutions to reduce burdens on hospitals
Technology solutions to remotely monitor and treat
Supporting the wellbeing and morale of NHS workforce
Solutions to support the Physical and Mental wellbeing of NHS employees
Assistance for those who are most Vulnerable and in Self Isolation
Ensuring the most vulnerable continue to get vital services and support they need
Solutions to reduce stress, anxiety, loneliness for the ill and their families
This communication, is being made available by or on behalf of Barclays Bank UK PLC (“Barclays”), and is for the exclusive use of the persons to whom it is issued (and their advisers) for the sole purpose of considering the request set out above.
Recipients agree with Barclays to keep, and ensure its advisers keep, confidential at all times information contained in this communication, and that the communications shall not be copied, reproduced or distributed or disclosed (in whole or in part) by recipients to any other person, in each case without the prior written consent of Barclays, nor should any other person act on it. By accepting this document, you also agree with Barclays to be bound by the following conditions and limitations.
The communication does not constitute, and Barclays has not provided (and will not provide) investment, professional, legal or tax advice, or a recommendation (personal or otherwise) with respect to any potential transaction, securities or financial instruments.
Neither Barclays nor any of its subsidiaries or affiliates, nor any director, officer, employee or agent of Barclays, makes any warranty or representation, express or implied, as to the accuracy, reliability or completeness of the information contained in this communication, whether obtained from or based upon third party sources or otherwise. Neither Barclays, nor any of its subsidiaries or affiliates, nor any officer, director, employee or agent of Barclays or any of its subsidiaries or affiliates, accepts any liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of any communication or its contents or reliance on the information contained therein. Nothing in this document excludes liability for, or remedy in respect of, fraud or fraudulent misrepresentation.
This document and any non-contractual obligations arising in connection with it shall be governed by and construed in accordance with English law.
Barclays Bank UK PLC. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority (Financial Services Register No. 759676). Registered in England.
Registered no. 9740322 Registered Office: 1Churchill Place, London E14 5HP.